touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss the case-based implementation of

The multidisciplinary team:

• Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.

For further information visit our website: 

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss key considerations in the management of immune-related adverse events with immune checkpoint inhibitors in advanced or recurrent endometrial cancer

The multidisciplinary team:

• Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.

For further information visit our website: 

touchMDT for touchONCOLOGY

Listen to key experts from a multidisciplinary team discuss improving outcomes with immune checkpoint inhibitors in advanced or recurrent endometrial cancer.

The multidisciplinary team:

• Gynaecological oncologist: Prof. Christian Marth, Innsbruck, Austria

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical educational grant from GlaxoSmithKline. This activity is provided by touchIME.

For further information visit our website: 

https://touchoncology.com/education/mdt-for-ici-in-ec/

touchIN CONVERSATION for touchHAEMATOLOGY

Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis. 

They respond to questions submitted by the HCP audience and provide expert insights on:

• The key considerations when selecting a first-line JAK inhibitor

This touchPODCAST is for HCPs only. 

For further information visit our website: 

touchIN CONVERSATION for touchONCOLOGY

Listen to Prof. John Mascarenhas (Icahn School of Medicine at Mount Sinai, New York, NY, USA) in conversation with Dr Raajit Rampal (Memorial Sloan Kettering Cancer Center, New York, NY, USA) on how to optimize the use of JAK inhibitors for patients with myelofibrosis. 

They respond to questions submitted by the HCP audience and provide expert insights on: 

• The key considerations when selecting a first-line JAK inhibitor 
  

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.

For further information visit our website:

touchPANEL DISCUSSION for touchONCOLOGY

Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake. 

The experts:

• Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa,

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. 

For further information visit: touchONCOLOGY

touchPANEL DISCUSSION for touchINFECTIOUS DISEASES

Listen to a panel of leading experts discuss the importance of HPV vaccination in preventing HPV-associated cancers, World Health Organization guidance on vaccine eligibility and scheduling, as well as strategies to improve HPV vaccination uptake. 

The experts:

• Prof. Lynette Denny GCOB (Silver), University of Cape Town, Cape Town, South Africa,

This touchPODCAST is for HCPs only. 

This activity is funded by an independent medical education grant from Merck & Co., Inc. and is jointly provided by USF Health and touchIME. 

For further information visit: touchINFECTIOUS DISEASES

touchEXPERT OPINIONS for touchONCOLOGY

Listen to three leading experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with metastatic colorectal cancer. 

The experts

• Dr Andrew Wotherspoon - Royal Marsden Hospital, London, UK;

This touchPODCAST is for HCPs only.

This activity is funded by an independent medical educational grant from Seagen Inc., and is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.org/fulfilling_the_potential_of_her2_targeting_in_crc/

touchCLINICAL PERSPECTIVES for touchNEUROLOGY - Module 1 & 2 

Module 1

Listen first to an expert provide their insights on the burden of migraine for patients, the need for effective preventive therapy and the currently available preventive treatment options.

The expert

Module 2

Listen next to a patient advocate providing her insights on the burden of migraine for patients and then to a clinical expert as he shares his perspectives on how real-world data for anti-CGRP antibodies can inform treatment optimization.

The patient advocate 

The clinical expert

• This touchPODCAST is for HCPs only.

For further information visit our website: